SCHEMBL2158392

SCHEMBL2158392

O=C(CCc1cccc(OC(F)(F)F)c1)N1CCN(CCOc2ccc(F)cc2F)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
ABCB1 P08183 2/20 0.43
DRD3 P35462 3/20 0.42
CACNA1F O60840 2/20 0.42
DRD4 P21917 2/20 0.42
DRD5 P21918 2/20 0.42
HRH2 P25021 2/20 0.42
ADRA1D P25100 2/20 0.42
HTR2A P28223 2/20 0.42
HTR7 P34969 2/20 0.42
ADRA1A P35348 2/20 0.42
HRH1 P35367 2/20 0.42
ADRA1B P35368 2/20 0.42
OPRM1 P35372 2/20 0.42
OPRD1 P41143 2/20 0.42
OPRK1 P41145 2/20 0.42
HTR6 P50406 2/20 0.42
CACNA1D Q01668 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2157760 0.93 GAA (0.46) SIGMAR1KMT2AMEN1ABCB1DRD3
SCHEMBL2157319 0.90 DRD3 (0.48) KMT2AMEN1DRD3CACNA1FDRD4
SCHEMBL2158378 0.89 KCNA5 (0.51) SIGMAR1KMT2ADRD3CACNA1FDRD4
SCHEMBL2157289 0.85 DRD3 (0.47) SIGMAR1KMT2AMEN1DRD3CACNA1F
SCHEMBL2157515 0.84 EPHX2 (0.44) SIGMAR1KMT2AMEN1DRD3CACNA1F
SCHEMBL2157523 0.82 KCNA5 (0.49) SIGMAR1KMT2AABCB1DRD3CACNA1F
SCHEMBL2158117 0.82 HRH3 (0.51) DRD3HRH2HRH1KCNA5EPHX2
Hydrochloric Acid SCHEMBL2158399 0.81 KCNA5 (0.48) SIGMAR1KMT2AABCB1DRD3CACNA1F
SCHEMBL2157428 0.80 HTR2A (0.47) SIGMAR1KMT2AMEN1DRD3CACNA1F
SCHEMBL2157298 0.79 DRD3 (0.45) KMT2AMEN1DRD3CACNA1FDRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183374-B2 Piperidine and piperazine derivatives M'S SCIENCE CORPORATION (JP) 2012-05-22 US disclosed
EP-2340835-A1 Piperidine and piperazine derivatives M's Science Corporation (JP) 2011-07-06 EP disclosed
EP-1976525-B1 PIPERIDINE AND PIPERAZINE DERIVATIVES MS SCIENCE CORP (JP) 2010-11-03 EP disclosed
US-20100137334-A1 Piperidine and Piperazine Derivatives SUN CONNIE L 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137334-A1 Piperidine and Piperazine Derivatives SIGMAR1, OPRM1, OPRD1 SIGMAR1 1/4885KMT2A 1809/4885MEN1 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.